Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine
- PMID: 6143964
- DOI: 10.1016/s0140-6736(84)92323-7
Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine
Abstract
A randomised, double-blind, placebo-controlled trial was conducted to evaluate the ability of RIT 4237 live attenuated bovine rotavirus (subgroup 1) vaccine strain to protect against natural rotavirus infection in children. 178 infants aged 8 to 11 months received a single oral dose of RIT 4237 vaccine or placebo and were followed up serologically and clinically during a subgroup 2 rotavirus epidemic. No side-effects attributable to the vaccine were observed. During the 5 months' observation after vaccination 2 of the 86 vaccine recipients and 18 of 92 placebo recipients had rotavirus diarrhoea lasting more than 24 h (p less than 0.001). The vaccine-protection rate was thus 88%. The 2 children in the vaccine group with rotavirus diarrhoea were regarded as primary vaccine failures since they had no detectable serum antibody responses after vaccination. Vaccine prepared from RIT 4237 strain of attenuated bovine rotavirus thus seems to protect children against heterologous subgroup 2 rotavirus diarrhoea.
Similar articles
-
[Anti-rotavirus vaccinations].Arch Pediatr. 1999 Sep;6(9):979-84. doi: 10.1016/s0929-693x(99)80593-4. Arch Pediatr. 1999. PMID: 10519034 Review. French.
-
Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young children.Rev Infect Dis. 1989 May-Jun;11 Suppl 3:S539-46. doi: 10.1093/clinids/11.supplement_3.s539. Rev Infect Dis. 1989. PMID: 2548276 Review.
-
Evaluation of RIT 4237 bovine rotavirus vaccine in newborn infants: correlation of vaccine efficacy to season of birth in relation to rotavirus epidemic period.Scand J Infect Dis. 1990;22(3):269-78. doi: 10.3109/00365549009027047. Scand J Infect Dis. 1990. PMID: 2164706 Clinical Trial.
-
Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age.Am J Dis Child. 1990 Mar;144(3):285-9. Am J Dis Child. 1990. PMID: 2154925 Clinical Trial.
-
Efficacy of two doses of RIT 4237 bovine rotavirus vaccine for prevention of rotavirus diarrhoea.Acta Paediatr Scand. 1991 Feb;80(2):173-80. doi: 10.1111/j.1651-2227.1991.tb11830.x. Acta Paediatr Scand. 1991. PMID: 1852084 Clinical Trial.
Cited by
-
The performance of licensed rotavirus vaccines and the development of a new generation of rotavirus vaccines: a review.Hum Vaccin Immunother. 2021 Mar 4;17(3):880-896. doi: 10.1080/21645515.2020.1801071. Epub 2020 Sep 23. Hum Vaccin Immunother. 2021. PMID: 32966134 Free PMC article. Review.
-
Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines.Vaccines (Basel). 2020 Jun 27;8(3):341. doi: 10.3390/vaccines8030341. Vaccines (Basel). 2020. PMID: 32604982 Free PMC article. Review.
-
Chapter 9 Infections caused by rubella, reoviridae, retro, Norwalk and ronaviruses.Perspect Med Virol. 1985;1:405-444. doi: 10.1016/S0168-7069(08)70017-X. Epub 2008 May 29. Perspect Med Virol. 1985. PMID: 32287581 Free PMC article.
-
Reverse Genetics System for a Human Group A Rotavirus.J Virol. 2020 Jan 6;94(2):e00963-19. doi: 10.1128/JVI.00963-19. Print 2020 Jan 6. J Virol. 2020. PMID: 31645445 Free PMC article.
-
Rotavirus epidemiology and vaccine demand: considering Bangladesh chapter through the book of global disease burden.Infection. 2018 Feb;46(1):15-24. doi: 10.1007/s15010-017-1082-4. Epub 2017 Oct 19. Infection. 2018. PMID: 29047020 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
